---
title: "Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294514055.md"
description: "Plus Therapeutics will rebrand to Cerenome on August 3, 2026. Nasdaq trading will switch to the ticker symbol CNSY at market open that day. The company's listing status remains unchanged, and shareholder ownership interests are not affected by this corporate name change."
datetime: "2026-07-31T12:32:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294514055.md)
  - [en](https://longbridge.com/en/news/294514055.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294514055.md)
generator: "portal-rs"
---

# Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3

-   Plus Therapeutics will complete its rebrand to Cerenome on Aug. 3, 2026. \* Nasdaq Capital Market trading will switch to ticker CNSY at the market open on Aug. 3. \* Stock listing status remains unchanged; the change does not alter shareholders’ ownership interests. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310830PRIMZONEFULLFEED9801613) on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PSTV.US](https://longbridge.com/en/quote/PSTV.US.md)
- [CNSY.US](https://longbridge.com/en/quote/CNSY.US.md)

## Related News & Research

- [Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook](https://longbridge.com/en/news/296058426.md)
- [Cerenome Launches as an Integrated CNS Oncology Company | PSTV Stock News](https://longbridge.com/en/news/294514925.md)
- [Plus Therapeutics amends bylaws to reflect corporate name change to Cerenome](https://longbridge.com/en/news/294876172.md)
- [Plus Tx rebrands as Cerenome as it deepens AI strategy](https://longbridge.com/en/news/291407890.md)
- [Billionaire Ray Dalio says today's artificial intelligence (AI) market echoes 1929 and 2000. History says investors should watch valuations closely](https://longbridge.com/en/news/296141586.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**